Myriad Genetics (MYGN) Other Working Capital Changes (2009 - 2026)

Myriad Genetics has disclosed Other Working Capital Changes across 18 years of filings, most recently posting $9.7 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 340.91% year-over-year to $9.7 million; the TTM figure through Mar 2026 stood at $7.3 million (up 630.0% YoY), while the FY2025 annual figure was -$200000.0, down 113.33% from the prior year.
• Other Working Capital Changes climbed to $9.7 million in Q1 2026, from -$1.8 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for MYGN reached as high as $9.7 million in Q1 2026 and fell as low as -$5.3 million in Q2 2022.
• The 5-year median for Other Working Capital Changes is $300000.0 (2024), against an average of $541176.5.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes tumbled 3900.0% — and 2025, when it surged 1200.0%.
• A 5-year view of Other Working Capital Changes shows it stood at -$4.0 million in 2022, then increased by 20.0% to -$3.2 million in 2023, then surged by 109.38% to $300000.0 in 2024, then plunged by 700.0% to -$1.8 million in 2025, then jumped by 638.89% to $9.7 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $9.7 million, -$1.8 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.